3D printing in healthcare market seen nearly doubling by 2030

The Business Research Company says the 3D printing in healthcare market will grow from $2.95 billion in 2026 to $5.99 billion by 2030, driven by demand for personalized care, bioprinting and point-of-care manufacturing. North America led the market in 2025, while Asia Pacific is expected to post the fastest growth.

Why it matters: - 3D printing is moving deeper into healthcare workflows, with uses that range from patient-specific devices to surgical planning models. - The market’s projected growth signals broader adoption of personalized medical products and digitally manufactured devices. - Rising chronic disease rates are increasing demand for customized implants and treatment tools.

What happened: - The Business Research Company released its 2026 report on the global 3D printing in healthcare market on July 23, 2026. - The market is projected to rise from $2.47 billion in 2025 to $2.95 billion in 2026. - The report forecasts the market will reach $5.99 billion by 2030. - North America held the largest market share in 2025. - Asia Pacific is expected to grow the fastest during the forecast period. - The report covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa as well.

The details: - The 2026-to-2030 forecast implies a 19.4% CAGR. - The 2025-to-2026 increase reflects a 19.3% CAGR. - Growth drivers include additive manufacturing advances, early use of 3D printed surgical guides, academic research, wider use of anatomical models and more printable biomaterials. - The report also points to rising funding for bioprinting research, stronger demand for personalized healthcare products and more regulatory approvals for printed medical devices. - Additional growth areas include regenerative medicine, point-of-care manufacturing, patient-specific medical devices, customized surgical models, 3D printed implants and prosthetics, and closer links between digital design and manufacturing. - 3D printing in healthcare means building three-dimensional medical objects layer by layer from digital designs. - The technology is used for patient-specific medical devices, anatomical models for education and surgery planning, and customized surgical instruments. - The report cites June 2024 NHS data showing 3,615,330 people in England registered with general practitioners were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, up 18% from 3,065,825 in 2022. - The report says chronic diseases such as diabetes, hypertension and arthritis are becoming more common because of sedentary behavior, processed-food diets and tobacco and alcohol use. - The 2026 edition adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables. - The report is available as a free sample and as the full market report through the company’s website: More information and the full report.

Between the lines: - The report frames 3D printing as a shift from prototyping to clinical production and personalized care. - The focus on regulatory approvals and point-of-care manufacturing suggests the market is moving beyond research into more operational healthcare use. - Chronic disease growth gives the technology a large and durable demand base because many cases require individualized devices or treatment support.

What's next: - The market’s next phase will likely hinge on bioprinting investment, broader clinical adoption and more regulatory clearances. - Asia Pacific’s expected growth points to a widening regional race for healthcare manufacturing capacity and personalized medicine tools. - The company expects digital design integration and printed implants and prosthetics to remain key trend areas through the forecast period.